Philadelphia, PA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of Aurlumyn ™ (iloprost IV), the only FDA approved ...
The current health care environment demands an ‘all-of-the-above’ approach – more private-sector competition, health insurance flexibility, greater price transparency, and myriad other reforms. For ...
In June 2024, Dr. Ivana Tadic was elected as president of the Pharmaceutical Care Network Europe (PCNE) board, and the Department of Clinical Pharmacy, under the leadership of Univ.-Prof. Dr. Anita ...
Health care has largely taken a back seat during the presidential campaign and the lack of focus has left the public wanting more. Two in three Americans (67%) surveyed by Gallup and West Health (Sept ...